Cryer, B.
184  Ergebnisse:
Personensuche X
?
1

P1935Pharmacokinetic and pharmacodynamic assessment of a li..:

Angiolillo, D J ; Bhatt, D L ; Lanza, F...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
 
?
2

The effects of proton pump inhibition on patient‐reported s..:

Vardi, M. ; Cryer, B. L. ; Cohen, M....
Alimentary Pharmacology & Therapeutics.  42 (2015)  3 - p. 365-374 , 2015
 
?
5

Risk factors for NSAID‐associated upper GI clinical events ..:

Laine, L. ; Curtis, S. P. ; Cryer, B...
Alimentary Pharmacology & Therapeutics.  32 (2010)  10 - p. 1240-1248 , 2010
 
?
7

Three‐year oral pantoprazole administration is effective fo..:

METZ, D. C. ; COMER, G. M. ; SOFFER, E....
Alimentary Pharmacology & Therapeutics.  23 (2006)  3 - p. 437-444 , 2006
 
?
8

Long-term results of phosphorylcholine-coated triplex stent..:

Dubé, H.M. ; Cryer, B ; Clifford, A.G...
Cardiovascular Revascularization Medicine.  7 (2006)  2 - p. 106 , 2006
 
?
9

Upper gastrointestinal tolerability of once weekly alendron..:

Cryer, B. ; Miller, P. ; Petruschke, R. A....
Alimentary Pharmacology & Therapeutics.  21 (2005)  5 - p. 599-607 , 2005
 
?
10

Effect of cyclooxygenase‐2 inhibition on human Helicobacter..:

Scheiman, J. M. ; Greenson, J. K. ; Lee, J..
Alimentary Pharmacology & Therapeutics.  17 (2003)  12 - p. 1535-1543 , 2003
 
?
 
?
 
1-15